MARKET

VRXA

VRXA

Veraxa Biotech AG
NASDAQ
1.800
-0.060
-3.23%
Pre Market: 1.850 +0.05 +2.78% 07:13 07/27 EDT
OPEN
1.890
PREV CLOSE
1.860
HIGH
1.950
LOW
1.780
VOLUME
3.78K
TURNOVER
--
52 WEEK HIGH
27.36
52 WEEK LOW
1.700
MARKET CAP
295.26M
P/E (TTM)
8.40
1D
5D
1M
3M
1Y
5Y
1D
VERAXA Biotech Advances Bispecific ADC VXA‑222 With OmniAb Milestone, Moving Alliance Into Next Phase Of Cancer Therapy Discovery
Benzinga · 8m ago
Weekly Report: what happened at VRXA last week (0720-0724)?
Weekly Report · 36m ago
Veraxa Biotech shareholders approved all proposals at extraordinary general meeting
PUBT · 2d ago
VERAXA BIOTECH SHAREHOLDERS APPROVE ALL PROPOSALS AT EXTRAORDINARY GENERAL MEETING, STRENGTHENING STRATEGIC FLEXIBILITY FOR FUTURE GROWTH
Reuters · 2d ago
VERAXA Biotech AG (NASDAQ: VRXA) Appoints Christoph Erkel as Chief Scientific Officer
TipRanks · 2d ago
VERAXA Biotech (NASDAQ: VRXA) Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany
TipRanks · 3d ago
Veraxa Biotech names Christoph Erkel chief scientific officer, succeeding Rick Austin
PUBT · 4d ago
VERAXA Biotech (NASDAQ: VRXA) Receives Regulatory Feedback for BiTAC-TCE Cancer Therapy Platform
TipRanks · 6d ago
More
About VRXA
Veraxa Biotech AG is a Switzerland-based Company that develops antibody-based therapeutics for the treatment of cancer. The Company focuses on advancing proprietary platform technologies designed to generate targeted oncology therapies with improved safety and efficacy profiles. Its approach originates from scientific discoveries at the European Molecular Biology Laboratory, supporting the development of next-generation antibody-based drug candidates. The Company aims to expand treatment options for solid tumors by enabling more precise targeting mechanisms and potentially broader therapeutic windows compared with conventional therapies, addressing unmet needs across oncology markets through platform-driven innovation.

Webull offers Veraxa Biotech AG stock information, including NASDAQ: VRXA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRXA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRXA stock methods without spending real money on the virtual paper trading platform.